Conference Proceedings

SIRFLOX: RANDOMISED PHASE III TRIAL COMPARING FIRST-LINE MFOLFOX6 /- BEVACIZUMAB (BEV) VERSUS MFOLFOX6 /- BEV plus SELECTIVE INTERNAL RADIATION THERAPY (SIRT) IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC) - ANALYSIS BY PRESENCE OR ABSENCE OF EXTRA-HEPATIC METASTASES, BEV TREATMENT AND SITE OF FIRST PROGRESSION

Peter Gibbs, Guy A van Hazel, Volker Heinemann, Navesh K Sharma, Michael PN Findlay, Jens Ricke, Marc Peeters, David Perez, Bridget Robinson, Andrew Strickland, Tom Ferguson, Javier Rodrigez, Hendrik Kroening, Ido Wolf, Vinod Ganju, Euan Walpole, Eveline Boucher, Thomas Tichler, Val Gebski, Mark Van Buskirk

Asia-Pacific Journal of Clinical Oncology | WILEY-BLACKWELL | Published : 2015